Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

December 31, 2025

Conditions

Primary Sclerosing CholangitisInflammatory Bowel Diseases

Interventions

DRUG

Rosuvastatin

Rosuvastatin 20 mg tablet once daily by mouth

Trial Locations (1)

RECRUITING

Stanford University, Stanford

All Listed Sponsors

lead

Stanford University

OTHER